Presentation Information
[P2-06-01]Clinical Stability Following a Switch to Migalastat in Fabry Disease with an Amenable GLA Variant (L300P)
Toru Awaya1, Masao Moroi2,3 (1. Department of Cardiovascular Medicine, kyorin University Hospital, 2. Department of Cardiovascular Medicine, Toho university Ohashi Medical Center, 3. Department of Internal Medicine, Misato Central General Hospital, Saitama, Japan)
Password required to view
Log in
or
